Action of cyclosporin A on mononuclear phagocytes

Journal of Investigational Allergology and Clinical Immunology

Volumn 6, Issue 4, 1996, Pages 222-231

  Garcia, Juan Emilio Losa ^a,c   Rodríguez, Fernando Mateos ^a   López, Antonio Jiménez ^a   Pérez Arellano, José Luis ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c NONE   (Spain)

Author keywords

Cyclosporin A; Macrophages; Monocytes; Mononuclear phagocytes

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2;

ANTIGEN EXPRESSION; CHEMOTAXIS; CYTOTOXICITY; IMMUNOMODULATION; MACROPHAGE; PHAGOCYTOSIS; REVIEW; T LYMPHOCYTE;

ANIMALS; CYCLOSPORINE; HUMANS; LEUKOCYTES, MONONUCLEAR; PHAGOCYTES;

EID: 0029764824     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Fahr, A. Cyclosporin clinical pharmacokinetics. Clin Pharmacokinet 1993, 24: 472-95
2. Feutren, G., von Graffenried, B. Pharmacology of cyclosporin A (Sandimmun ®) and clinical experience in inflammatory bowel diseases. Schweiz Med Wochenschr 1991, 121. 748-53.
3. Valdimarsson, H. Immunity during cyclosporine therapy J Am Acad Dermatol 1990. 23: 1294-300
4. Fathman, C.G , Myers, B.D. Cyclosporine therapy for autoimmune disease. N Engl J Med 1992, 326: 1693-5.
5. Hess, A.D., Colombani, P.M., Esa, A.H. Cyclosporine and the immune response: Basic aspects. Crit Rev Immunol 1986, 6: 123-49.
6. Ren, K., Van Liew, J.B., Noble, B. The effect of cyclosporin A on disease progression in proliferative immune complex glomerulonephritis. Clin Immunol Immunopathol 1993, 66. 107-113
7. Hess, A.D. Mechanisms of action of cyclosporine: Considerations for the treatment of autoimmune diseases. Clin Immunol Immunopathol 1993, 68: 220-8.
8. Ryffel, B., Willard-Gallo, K.E., Tammi, K., Loken, M.R. Quantitative fluorescence analysis of cyclosporine binding to human leukocytes. Transplantation 1984, 37. 276-80.
9. Schreiber, S L., Crabtree, G.R. The mechanism of action of cyclosporin A and FK-506. Immunol Today 1992, 13: 136-42.
10. Liu, J. FK-506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol Today 1993, 14: 290-5.
11. Cooper, M.H., Gregory, S.H , Starzl, T.E., Wing, E J. Rapamycin but not FK-506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors. Transplantation 1994, 57: 433-9.
12. Rezzani, R., Rodella, L., Corsetti, G., Ventura, R.G. Immunohistochemical study of cyclosporin-A on rat thymus after various treatment times. Boll Soc Ital Biol Sper 1994, 70: 119-23.
13. Milicevic, N.M., Milicevic, Z., Colic, M., Kamperdijk, E.W., Hoefsmit, E.C. Ultrastructural study of macrophages of the rat thymus after cyclosporin treatment. Thymus 1993, 22 35-44.
14. Thomson, A.W., Propper, D.J., Woo, J., Whiting, P.H., Milton, J.I., Macleod, A.M. Comparative effects of rapamycin, FK-506 and cyclosporine on antibody production, lymphocyte populations and immunoglobulin isotype switching in the rat Immunopharmacol Immunotoxicol 1993, 15. 355-69.
15. Reisman, L, Cooper, D., Lieberman, K.V., Martinelli, G.P Cyclosporine suppresses IL-1 production by isolated human monocytes and by the human histiocytoma cell line. THP-1. Transplant Proc 1990, 22: 1744-6.
16. Goldin, H., Keisan, Y The effect of cyclosporine on macrophage oxidative burst potential during graft-versus-host reactions in mice. Transplantation 1989; 47 548-52.
17. Helin, H J., Edgington, T.S. Cyclosporin A regulates monocyte/ macrophage effector functions by affecting instructor T cells: Inhibition of monocyte procoagulant response to allogeneic stimulation. J Immunol 1984, 132: 1074-6.
18. Yoshimura, N., Oka, T., Ohmori, Y., Aikawa, I , Fukuda, M., Kahan, B.D. Influence of in vivo cyclosporine on interleukin production in kidney transplant recipients. Transplant Proc 1987, 19: 1194-8.
19. Hidalgo, H A , Helmke, R.J., German, V.F., Mangos, J.A. The effects of cyclosporine and dexamethasone on an alveolar macrophage cell line (NR-8383). Transplantation 1992, 53: 620-23.
20. Andreesen, R., Gadd, S., Costabel, U., Leser, H.G., Speth, V., Cesnik, B., Atkins, R.C. Human macrophage maturation and heterogeneity: Restricted expression of late differentiation antigens in situ. Cell Tissue Res 1988; 253: 271-9.
21. Thomson, A W., Moon, D.K., Geczy, C.L., Nelson, D.S. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines. Immunology 1983, 48: 291-9.
22. Roth, J , Goebeler, M., Erpenstein, U., Sorg, C. Differential regulation of the macrophage-specific surface antigen RM3/1 by cyclosporine, azathioprine, and dexamethasone Transplantation 1994, 57: 127-33
23. Noga, S.J., Fischer, A.C., Wagner, J.E., Normann, SJ., Zucali, J.R., Esa, A.E , Hess, A D. Cyclosporine A enhances the natural suppressor monocyte precursor population in the rat. Transplant Proc 1988, 20 (Suppl 3). 1057-67.
24. Esa, A.M., Paxman, D G , Noga, S.J , Hess, A.D. Sensitivity of monocyte subpopulations to cyclosporine. Arachidonate metabolism and in vitro antigen presentation. Transplant Proc 1988, 20 (Suppl 2): 80-6
25. Wong, R L., Winslow, C M., Cooper, K.D The mechanism of action of cyclosporin A in the treatment of psoriasis Immunol Today 1993, 14: 69-74
26. Drath, D.B., Kahan, B.D. Alterations in rat pulmonary macrophage function by the immunosuppressive agents cyclosporine, azathioprine, and prednisolone. Transplantation 1983, 35: 588-92.
27. Drath, D.B., Kahan, B.D. Phagocytic cell function in response to immunosuppressive therapy. Arch Surg 1984, 119: 156-60.
28. Shennib, H., Padilla-Longoria, R., Chiu, R.C.J., Mudler, D.S. Preservation of alveolar macrophage function during immunosuppression: Cyclosporin A versus methylprednisolone. Surg Forum 1982, 33: 338-41.
29. Wasik, M.A , Beller, D.I. Induction of macrophage membrane interleukin 1 expression by T-cell dependent and T-cell independent pathways is inhibited by cyclosporin A. Clin Immunol Immunopathol 1989, 52: 331-40.
30. Chiara, M.D., Sobrino, F. Modulation of the inhibition of respiratory burst in mouse macrophages by cyclosporin A: Effect of in vivo treatment, glucocorticoids and the state of activation of cells. Immunology 1991, 72: 133-7.
31. Thomson, A.W. The effects of cyclosporin A on non-T cell components of the immune system. J Autoimmun 1992, 5 (Suppl. A): 167-76.
32. Whisler, R.L., Lindsey, J.A., Proctor, K.V., Newhouse, Y.G., Cornwell, D.G. The impaired ability of human monocytes to stimulate autologous and allogeneic mixed lymphocyte reactions after exposure to cyclosporine. Associated alterations of HLA-DR expression and physical characteristics of monocytes. Transplantation 1985, 40: 57-61.
33. Chiara, M.D., Bedoya, F., Sobrino, F. Cyclosporin A inhibits phorbol ester-induced activation of Superoxide production in resident mouse peritoneal macrophages. Biochem J 1989, 264: 21-6.
34. Palay, D.A., Cluff, C.W., Wentworth, P.A., Ziegler, H.K. Cyclosporine inhibits macrophage-mediated antigen presentation. J Immunol 1986, 136: 4348-53.
35. Thomson, A.W., Moon, D.K., Nelson, D.S. Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse. Clin Exp Immunol 1983, 52: 599-606.
36. Manca, F., Fenoglio, D., Kunkl, A., Caltabellotta, M., Celada, F. Effect of cyclosporine on the antigen-presenting function of human and murine accessory cells. Transplantation 1988, 46 (2 Suppl.): 40S-43S.
37. Mrowietz, U., Christophers, E. Effects of cyclosporine A treatment on psoriasis. I. Influence of low-dose cyclosporine on human monocyte function in vitro. Transplant Proc 1988, 20 (Suppl. 4): 53-7.
38. Yocum, D. Immunological actions of cyclosporin A in rheumatoid arthritis. Br J Rheumatol 1993, 32 (Suppl. 1): 38-41.
39. Pigatto, P.D., Bersani, L, Altomare, G., Mozzanica, N., Finzi, A. Effects of cyclosporin A on psoriatic monocyte functions and secretion. Acta Derm Venereol Suppl Stochk 1989, 146: 165-7.
40. Kawahara, K., Itoh, S., Honjou, S., Tagawa, Y., Akamine, S., Takahashi, T., Ayabe, H., Tomita, M The RNA content of alveolar macrophages in canine lung allografts. J Surg Res 1993,55:131-4.
41. Granelli Piperno, A., Keane, M. Effects of cyclosporine A on T lymphocytes and accessory cells from human blood. Transplant Proc 1988, 20 (Suppl. 2): 136-42.
42. Granelli-Pipemo, A., Keane, M., Steinman, R.M. Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the Tlymphocyte rather than the accessory cell Transplantation 1988, 46 (2 Suppl.): 53S-60S.
43. Nguyen, D.T., Eskandai, M.K., DeForge, L.E , Raiford, C.L., Strieter, R.M., Kunkel, S.L., Remick, D.G. Cyclosponn A modulation of tumor necrosis factor gene expression and effects in vitro and in vivo. J Immunol 1990, 144. 3822-8.
44. Gupta, S.K , Curtis, J., Turk, J.L The effect of hydrocortisone and cyclosporin A on bacillus Calmette-Guerin epitheloid cell granulomas. Cell Immunol 1985, 93 189-98.
45. Yamaguchi, Y., Misumi, M., Mori, K., Takata, N., Goto, M., Makino, Y , Kikuchi, N , Hamaguchi, H., Hisama, N., Takeya, M et al Effect of cyclosporine on distribution of macrophage subpopulations in rat hepatic allograft. Dig Dis Sci 1993, 38: 619-25.
46. Sawada, M., Suzumura, A., Marunouchi. T. Down regulation of CD4 expression in cultured microglia by immunosuppressants and lipopolysacchande Biochem Biophys Res Commun 1992, 189 869-76
47. Petzelbauer, P., Wolff, K. Effects of cyclosporin A on resident and passenger immune cells of normal human skin and UV-induced erythema reactions. Br J Dermatol 1992, 127: 560-5.
48. Russell, R.G., Graveley, R., Coxon, F., Skjodt, H., Del Pozo, E., Elford, P., MacKenzie, A. Cyclosporin A Mode of action and effects on bone and joint tissues. Scand J Rheumatol 1992, 21 (Suppl 95): 9-18.
49. Snyder, D.S , Wright, C.L., Ting, C. Inhibition of human monocyte antigen presentation, but not HL A-DR expression, by cyclosporine. Transplantation 1987, 44. 407-11.
50. Yonish-Rouach, E., Fischer, D.G., Rubinstein, M. Cyclosporin A regulates the expression of HLA-DR on human monocytes by two different mechanisms. Cell Immunol 1991, 134: 402-13.
51. Manca, F., Kunkl, A., Celada, F. Inhibition of the accessory function of murine macrophages in vitro by cyclosporine. Transplantation 1985, 39: 644-9.
52. Fan, T.P., Lewis, G.P. Mechanism of cyclosporin A - Induced inhibition of prostacyclin synthesis by macrophages. Prostaglandins 1985, 30. 735-47
53. Tanner, M.K., Wellhausen, S.R , Klein, J.B. Flow cytometric analysis of altered mononuclear cell transmembrane potential induced by cyclosporin. Cytometry 1993, 14: 59-69.
54. Tipton, D.A., Pabst, M.J., Dabbous, M.K. Interleukin-1 beta- and tumor necrosis factor-alpha-independent monocyte stimulation of fibroblast collagenase activity. J Cell Biochem 1990, 44: 253-64.
55. Rordorf-Adam, C., Lazdins, J., Woods-Cook, K., Alteri, E., Henn, R., Geiger, T., Feige, V., Towbin, H., Erard, F. An assay for the detection of interleukin-1 synthesis inhibitors: Effects of antirheumatic drugs. Drugs Exp Clin Res 1989, 15. 355-62.
56. Gepner, P., Amor, B., Fournier, C. 1,25-dihydroxyvitamin D3 potentiates the in vitro inhibitory effects of cyclosporin A on T cells from rheumatoid arthritis patients. Arthritis Rheum 1989, 32: 31-6.
57. Tocci, M.J., Matkovich, D.A., Collier, K.A., Kwok, P., Dumont, F., Lin, S., Degudicibus, S., Siekierka, J.J., Chin, J., Hutchinson, N.I. The immunosuppressant FK-506 selectively inhibits expression of early T cell activation genes. J Immunol 1989, 143: 718-26.
58. Salomon, D.R., Boerth, L.W., Rocher, L.L., Pennington, J.E. Dose-dependent reduction in alveolar macrophage populations during cyclosporine treatment. Clin Res 1985, 33: 581A.
59. Keicho, N., Sawada, S , Kitamura, K., Yotsumoto, H., Takaku, F. Effects of an immunosuppressant, FK-506, on interleukin 1 alpha production by human macrophages and a macrophage-like cell line, U937. Cell Immunol 1991, 132: 285-94.
60. Espevik, T., Figari, I S., Shalaby, M.R., Lackides, G.A., Lewis, G.D., Shepard, H.M., Palladino, M.A. Jr. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med 1987, 166: 571-6.
61. Andersson, J., Nagy, S., Groth, C.G., Andersson, U. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 1992, 75: 136-42.
62. Pigatto, P.D., Pigatto, L.B., Bigardi, A., Altomare, G., Finzi, A.F. Factors secreted by untreated psoriatic monocytes enhance neutrophil functions. J Invest Dermatol 1990, 94. 372-6.
63. Remick, D G., Nguyen, DT., Eskandari, M K., Stricter, R.M., Kunkel, S. L Cyclosponne A inhibits TNF production without decreasing TNF mRNA levels. Biochem Biophys Res Commun 1989, 161: 551-5
64. Rofe, A.M., Philcox, J.C., Haynes, D.R., Whitehouse, M.W., Coyle, P. Changes in plasma zinc, copper, iron, and hepatic metallothionein in adjuvant-induced arthritis treated with cyclosporin Biol Trace Elem Res 1992, 34. 237-48.
65. Tadmori, W., Mondal, D., Tadmori, I., Prakash, O Transactivation of human immunodeficiency virus type 1 long terminal repeats by cell surface tumor necrosis factor alpha. J Virol 1991. 65. 6425-9
66. Hsi, E.D , Remick, D.G. Rapid determination of cell-associated tumor necrosis factor production by flow cytometry Lab Invest 1993, 68: 740-5
67. Moutabarnk, A . Takahara, S., Namiki, M., Kokado, Y , Seguchi, T., Yokokawa, K., Takano, Y., Zaid. D., Ishibashi, M , Okuyama, A Effect of FK-506 and cyclosporine on the expression of IL-6 and its receptor on stimulated monocytes. Transplant Proc 1993. 25-2320-1
68. Kato, K., Yokoi, T., Takano, N., Kanegane, M., Yachie, A., Miyawaki, T , Taniguchi, N. Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood. J Immunol 1990, 144: 1317-22.
69. Mrowietz, U., Sticherling, M , Mielke, V., Schroder, J.M., Christo phers, E Neutrophil-activating peptide 1/interleukin 8 mRNA expression and protein secretion by human monocytes: Effect of cyclosporin A Cytokine 1991, 3: 322-6.
70. Brach, M.A., Gruss, H.J , Riedel, D., Asano, Y., De Vos, S., Herrmann, F. Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes. Mol Pharmacol 1992, 42: 63-8.
71. Metzger, J.M., Peterson, L.B. Cyclosporin A enhances the pulmonary granuloma response induced by Schistosoma mansoni eggs. lmmunopharmacology 1988, 15: 103-15.
72. Whisler, R.L., Lindsey, J A , Proctor, K.V., Monsaki, N., Comwell, D.G. Characteristics of cyclosponne induction of increased prostaglandin levels from human peripheral blood monocytes. Transplantation 1984, 38. 377-81.
73. Sraer, J., Bens, M., Ardaillou, R. Dual effects of cyclosporine A on arachidonate metabolism by peritoneal macrophages. Phospholipase activation and partial thromboxane-synthase blockage. Biochem Pharmacol 1989, 38: 1947-54.
74. Chiara, M.D., Foot, A.B., Sobrino, F , Jones, O.T. Differential effect of cyclosporine A on respiratory burst by several types of human leukocytic cells. Biochem Int 1991, 23: 1185-93.
75. Wenzel-Seifert, K , Schachtele, C., Hummel, R., Grunbaum, L., Seifert, R. Evidence that inhibition of phorbol ester-induced superoxide anion formation by cyclosporin A in phagocytes is not mediated by direct inhibition of protein kinase C. Biochem Pharmacol 1994, 48: 859-64
76. Burkart, V , Imai, Y., Kallmann, B , Kolb, H. Cyclosporin A protects pancreatic islet cells from nitric oxide-dependent macrophage cytotoxicity. FEBS Lett 1992, 313. 56-8.
77. Carlsen, E., Prydz, H. Enhancement of procoagulant activity in stimulated mononuclear blood cells and monocytes by cyclosporine. Transplantation 1987, 43: 543-8.
78. Carlsen, E., Mallet, A.C., Prydz, H Effect of cyclosporine A on procoagulant activity in mononuclear blood cells and monocytes in vitro. Clin Exp Immunol 1985, 60: 407-16.
79. Carlsen, E., Flatmark, A., Prydz, H. Cytokine-induced procoagulant activity in monocytes and endothelial cells. Further enhancement by cyclosporine. Transplantation 1988, 46: 575-80.
80. Montemurro, P., Coluccia, M , De-Nicolo, L , Colucci, M , Semeraro, N. Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice. Pharmacol Res Commun 1988, 20: 255-64.
81. Shaw, A.J., Hayes, M.E., Davies, M., Edwards, B D., Ballardie, F.W., Chalmers, R.J., Mawer, E.B. Cyclosporin A and vitamin D metabolism: Studies in patients with psoriasis and in rats Clin Sci Colch 1994, 86 627-32.
82. Simons, J.W., Noga, S.J , Colombani, P.M., Beschorner, W.E , Coffey, D.S., Hess, A.D. Cyclosponne A, an in vitro calmodulin antagonist, induces nuclear lobulations in human T cell lymphocytes and monocytes. J Cell Biol 1986, 102: 145-50
83. Hodgkinson, S.J., Westland, K.W., Pollard, J.D Transfer of experimental allergic neuntis by intra neural injection of sensitized lymphocytes. J Neurol Sci 1994, 123: 162-72
84. Nogueira-de-Francischi, J., Conroy, D.M., Maghni, K., Sirois, P. Inhibition by rapamycin of leukocyte migration and bronchial hyperreactivity induced by injection of Sephadex beads to guinea-pigs. Br J Pharmacol 1993, 110: 1381-6.
85. Drath, D.B., Kahan, B.D. Pulmonary macrophage and polymorphonuclear leukocyte function in response to immunosuppressive therapy. Transplant Proc 1983, 15 (Suppl. 1) 2367-72.
86. Adams, D.H., Wang, L.F., Neuberger, J.M., Elias, E. Inhibition of leukocyte chemotaxis by immunosuppressive agents. Specific inhibition of lymphocyte chemotaxis by cyclosporine. Transplantation 1990, 50: 845-50.
87. Kharazmi, A., Svenson, M., Nielsen, H., Birgens, H.S. Effect of cyclosporin A on human neutrophil and monocyte function. Scand J Immunol 1985, 21: 585-91.
88. Benson, A., Ziegler, H.K. Macrophages as targets for inhibition by cyclosporine. Transplantation 1989, 47: 696-703.
89. Lun, M.T., Gaeta, A., Brenciagtia, M.I., Cipriani, P., Mancini, C., Pretagostini, R., Alfani, D., Bigotti, G., Cochi, S., Mannella, E. Monocytes phagocytic activity in cyclosporine treated patients. Microbiologica 1985, 8: 277-82.
90. Plowman, P.N. Human pulmonary macrophages. Pinocytic activity in bronchial carcinoma and in the presence of levamisole and cyclosporin A. Clin Oncol 1982; 8: 39-48.
91. Yano, S., Sone, S., Nishioka, Y., Naito, M., Tsuruo, T., Ogura, T. Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes Jpn J Cancer Res 1994, 85: 194-203.
92. Wainberg, M.A., Dascal, A., Blain, N , Fitz-Gibbon, L, Boulerice, F., Numazaki, K., Tremblay, M. The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. Blood 1988, 72: 1904-10.
93. Numazaki, K., Nagata, N., Sato, T., Chiba, S. Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor alpha on infection of U-937 and MRC-5 cells by human cytomegalovirus. J Leukoc Biol 1994, 55: 24-8.
94. Wright, B., Greig, R., Poste, G. Inhibition of macrophage activation and tumor cell cytolysis by cyclosporin-A. Biochem Biophys Res Commun 1984, 123: 710-5.
95. Esa, A.H., Converse, P J., Hess, A.D. Cyclosporine inhibits soluble antigen and alloantigen presentation by human monocytes in vitro. Int J Immunopharmacol 1987, 9: 893-902
96. Losa García, J.E. Efecto de la ciclosporina sobre las céluls del sistema mononuclear fagocíco. Producción de citocinas inflamatorias Tesis Doctoral, Universidad de Salamanca, Salamanca 1994.
97. Jiménez López, A., Losa García, J.E., García Salgado, M.J., Mateos Rodriguez, F., Disdier, C., Pérez Arellano, J.L Effect of cyclosporin on inflammatory cytokine production by human alveolar macrophages. J Hung Soc Int Med 1994; 47: 89.